...
【24h】

Long-Term Evaluation of the Outcomes of Subtotal Laparoscopic and Robotic Splenectomy in Hereditary Spherocytosis

机译:遗传球致胞症患者腹腔镜和机器人脾切除术的长期评价

获取原文
获取原文并翻译 | 示例
           

摘要

Background Hereditary spherocytosis (HS) is a common inherited disease affecting the erythrocyte membrane. Total splenectomy (TS) is effective in reducing hemolysis and decreasing the need of transfusions, but total removal of the spleen represents a potential risk factor for infectious and non-infectious complications. On the other hand, subtotal splenectomy (STS) could be an alternative therapy for HS. The aim of this study is to establish which surgical approach has the best outcome in HS. Methods All patients (n = 63) receiving splenectomy for HS between 2002 and 2016 from one institution were retrospectively reviewed. Hemoglobin and reticulocytes levels during preoperative and postoperative follow-up periods were compared. Additionally, a meta-analysis was performed analyzing data regarding hemoglobin and reticulocytes levels from several available studies. Result At 1-year follow-up, our clinical data showed that mean hemoglobin levels increased after TS from (mean +/- SD) 9.77 +/- 1.82 to 11.88 +/- 2.08 g/dl, while after STS from 8.98 +/- 1.66 to 11.87 +/- 1.38 g/dl. At 3-year and 5-year follow-up after TS, we observed an increase from 9.77 +/- 1.82 to 13.59 +/- 2.03 and 13.46 +/- 1.64 g/dl, respectively. At 3-year and 5-year follow-up after STS in our cohort, we observed an increase from 8.98 +/- 1.66 to 13.21 +/- 1.95 and 13.68 +/- 1.65 g/dl, respectively. The meta-analysis (for a follow-up period of 1 year) showed that the hemoglobin levels increased with 2.61 g/dl (95% CI 2.15-3.08 g/dl; p < 0.001) after TS, and with 1.67 g/dl (95% CI 1.25-2.10 g/dl; p < 0.001) after STS. Conclusion We conclude that subtotal and minimally invasive splenectomy could be considered as the first line of treatment in severe HS cases, especially in children.
机译:背景技术遗传性球胶质织血症(HS)是影响红细胞膜的常见遗传疾病。总脾切除术(TS)有效减少溶血和减少输血的需要,但总去除脾脏是传染性和非传染性并发​​症的潜在危险因素。另一方面,小斑块切除术(STS)可以是HS的替代治疗。本研究的目的是建立哪种手术方法具有最佳结果。方法回顾性审查2002年至2016年2002年至2016年在2002年至2016年期间接受脾脏切除术的所有患者(n = 63)。比较术前和术后随访期间的血红蛋白和网状细胞水平。另外,通过几种可用研究进行了分析关于血红蛋白和网状细胞水平的数据的荟萃分析。结果在1年的随访中,我们的临床资料显示,来自(平均值+/- SD)9.77 +/- 1.82至11.88 +/- 2.08 g / dl后,平均血红蛋白水平增加,而STS从8.98 + / - 1.66至11.87 +/- 1.38 g / dl。在TS之后为期3年和5年的随访,我们观察到从9.77 +/- 1.82增加到13.59 +/- 2.03和13.46 +/- 1.64 G / DL。在我们的队列中圣署后3年和5年的随访,我们观察到从8.98 +/- 1.66增加到13.21 +/- 1.95和13.68 +/- 1.65 g / dl。 Meta分析(用于后续时间为1年)表明,TS后,血红蛋白水平增加了2.61g / dl(95%Ci 2.15-3.08g / dl; p <0.001)。 (95%CI 1.25-2.10 G / DL; P <0.001)。结论我们得出结论,伯滴和微创脾切除术可以被认为是严重HS病例中的第一线治疗,特别是儿童。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号